Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots.
In the Boston area, three months into the new year, the mood in the biotech industry has soured and the outlook has clouded.
‘The hangover can last longer than the party’: Biotech is in a major slump, with no end in sight
There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
Moderna CEO Stéphane Bancel received an annual compensation package worth $19.87 million last year, the largest he’s ever ...
23h
Investing News Network on MSNBird Flu Vaccine Stocks: 8 Companies Developing H5N1 VaccinesLife science companies developing bird flu vaccines are gaining attention as the avian influenza subtype H5N1 becomes an ...
The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.
The National Institutes of Health, which falls under the jurisdiction of HHS, has terminated grants for research into vaccine hesitancy, according to the Washington Post, even though the Texas measles ...
Barclays 27th Annual Global Healthcare Conference March 11, 2025 1:30 PM ETCompany ParticipantsRose Loughlin - EVP of ...
As we reflect on five years of COVID-19, it’s clear that the impacts are still unfolding. The life sciences—and we as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results